Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Emulate Logo
Emulate Growth Score
71
CB Rank
5682
Heat Score
66
Emulate creates advanced in vitro models for understanding how diseases, medicines, chemicals, and foods affect human health.
Founded
obfuscation
PrivateSeries F Boston, Massachusetts, United States51-100 emulatebio.com
Biotechnology
Health Care
Life Science
Medical
Pharmaceutical
Overview

Emulate
Total Funding
obfuscation
Growth Score
71
Heat Score
66

Total Funding
obfuscation
obfuscation
Series F raised
obfuscation
Growth Score71
-10 pts
in past quarter
Heat Score 66
-6 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Emulate

CB Rank
5682
Emulate creates advanced in vitro models for understanding how diseases, medicines, chemicals, and foods affect human health.
Founded
obfuscation
PrivateSeries F Boston, Massachusetts, United States51-100 emulatebio.com
Biotechnology
Health Care
Life Science
Medical
Pharmaceutical

Funding Rounds

Series F
OBF
in
obfuscation
Series E
OBF
in
obfuscation
Series D
OBF
in
obfuscation

Key People

Details

Legal Name Emulate Inc.
Operating Status Active
Company Type For Profit
Founders  Daniel Levner, Donald Ingber, Geraldine A. Hamilton
About the Company
Emulate is a privately held company that creates advanced in vitro models for understanding how diseases, medicines, chemicals, and foods affect human health.
Phone Number +1 781 583 3515
Contact Email jenn.perkins@emulatebio.com
Diversity Spotlight 
Women Founded
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

AVA™ Emulation System
A high-throughput Organ-Chip platform with built-in incubation, automated imaging, and AI-ready data generation for scalable in vitro human tissue modeling.
Zoë-CM2 Culture Module
A culture system that supports up to 12 Organ-Chips simultaneously, providing controlled microenvironmental conditions for model development and target validation.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 10
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series F - Emulate Logo
Series F - Emulate
1
obfuscation
— Series F
obfuscation
Series F - Emulate Logo
Series F - Emulate
1
obfuscation
— Series F
obfuscation
Series F - Emulate Logo
Series F - Emulate
1
obfuscation
— Series F
obfuscation
Series F - Emulate Logo
Series F - Emulate
1
obfuscation
— Series F
obfuscation
Series F - Emulate Logo
Series F - Emulate
1
obfuscation
— Series F

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 10
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series F - Emulate Logo
Series F - Emulate
1
obfuscation
— Series F
obfuscation
Series F - Emulate Logo
Series F - Emulate
1
obfuscation
— Series F
obfuscation
Series F - Emulate Logo
Series F - Emulate
1
obfuscation
— Series F
obfuscation
Series F - Emulate Logo
Series F - Emulate
1
obfuscation
— Series F
obfuscation
Series F - Emulate Logo
Series F - Emulate
1
obfuscation
— Series F

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 51-100 Employee Profiles 4 Board Members and Advisors 4 Contacts 99

Employee Profiles

Board Members and Advisors

News

News and Press

News•May 18, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Apr 18, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Feb 4, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jan 19, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

5,358
-52.18%
 in past month

IT Spend

$999.4KThis year, Emulate is projected to spend $999.4K on IT, according to Aberdeen.

Interest Signals

TopicSurge Score
Password Vault Logo
Password Vault
99
Amazon Web Services (AWS) Logo
Amazon Web Services (AWS)
97
Bitwarden Inc. Logo
Bitwarden Inc.
95

Actively Used Products

28Emulate uses 28 technology products and services including HTML5, Google Tag Manager, and  GoDaddy Premium DNS, according to G2 Stack.

Active Website Tech Count

23Emulate is actively using 23 technologies for its website, according to BuiltWith. These include DNSSEC, IPv6, and  Cloudflare Network Error Logging.

Total IP

153The intellectual property of Emulate includes 111 registered patents primarily in the 'Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering' category, according to IPqwery. Additionally, Emulate has registered 42 trademarks with the most popular class being 'Scientific and electric apparatus and instruments', according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Emulate's headquarters? Emulate is located in Boston, Massachusetts, United States.Who invested in Emulate? Emulate has 22 investors including Qiming Venture Partners and  Northpond Ventures.When was the last funding round for Emulate? Emulate closed its last funding round on
obfuscation
from a Series F round.Who are Emulate's competitors? Alternatives and possible competitors to Emulate may include XtalPi, Generate Biomedicines, and  Cellares.How much funding has Emulate raised to date? Emulate has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(9fd75b2 1)
|